Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Genetic variation in PBMC-produced IFN-γ and TNF-α associations with relapse in multiple sclerosis.

Zhou Y, Taylor B, van der Mei I, Stewart N, Charlesworth J, Blizzard L, Ponsonby AL, Dwyer T, Pittas F, Simpson S Jr.

J Neurol Sci. 2015 Feb 15;349(1-2):40-4. doi: 10.1016/j.jns.2014.12.022. Epub 2014 Dec 19.

PMID:
25575858
2.

Modulating effects of WT1 on interferon-β-vitamin D association in MS.

Lin R, Taylor BV, Charlesworth J, van der Mei I, Blizzard L, Stewart N, Ponsonby AL, Dwyer T, Pittas F, Simpson S Jr.

Acta Neurol Scand. 2015 Apr;131(4):231-9. doi: 10.1111/ane.12315. Epub 2014 Oct 14.

PMID:
25312909
3.

EBV & HHV6 reactivation is infrequent and not associated with MS clinical course.

Simpson S Jr, Taylor B, Burrows J, Burrows S, Dwyer DE, Taylor J, Ponsonby AL, Blizzard L, Dwyer T, Pittas F, van der Mei I.

Acta Neurol Scand. 2014 Nov;130(5):328-37. doi: 10.1111/ane.12268. Epub 2014 Jun 3.

PMID:
24893674
4.

Stimulated PBMC-produced IFN-γ and TNF-α are associated with altered relapse risk in multiple sclerosis: results from a prospective cohort study.

Simpson S Jr, Stewart N, van der Mei I, Otahal P, Charlesworth J, Ponsonby AL, Blizzard L, Dwyer T, Pittas F, Gies P, Taylor B.

J Neurol Neurosurg Psychiatry. 2015 Feb;86(2):200-7. doi: 10.1136/jnnp-2013-307336. Epub 2014 May 1.

PMID:
24790215
5.

Association between multiple sclerosis risk-associated SNPs and relapse and disability--a prospective cohort study.

Lin R, Taylor BV, Simpson S Jr, Charlesworth J, Ponsonby AL, Pittas F, Dwyer T, van der Mei I.

Mult Scler. 2014 Mar;20(3):313-21. doi: 10.1177/1352458513496882. Epub 2013 Jul 25.

PMID:
23886828
6.

Novel modulating effects of PKC family genes on the relationship between serum vitamin D and relapse in multiple sclerosis.

Lin R, Taylor BV, Simpson S Jr, Charlesworth J, Ponsonby AL, Pittas F, Dwyer T, van der Mei IA.

J Neurol Neurosurg Psychiatry. 2014 Apr;85(4):399-404. doi: 10.1136/jnnp-2013-305245. Epub 2013 Jul 18.

PMID:
23868949
7.

Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis.

Wood B, van der Mei IA, Ponsonby AL, Pittas F, Quinn S, Dwyer T, Lucas RM, Taylor BV.

Mult Scler. 2013 Feb;19(2):217-24. doi: 10.1177/1352458512450351. Epub 2012 Jun 22.

PMID:
22729988
8.

Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS.

Stewart N, Simpson S Jr, van der Mei I, Ponsonby AL, Blizzard L, Dwyer T, Pittas F, Eyles D, Ko P, Taylor BV.

Neurology. 2012 Jul 17;79(3):254-60. doi: 10.1212/WNL.0b013e31825fded9. Epub 2012 Jun 13.

PMID:
22700816
9.

Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis.

Simpson S Jr, Taylor B, Dwyer DE, Taylor J, Blizzard L, Ponsonby AL, Pittas F, Dwyer T, van der Mei I.

Mult Scler. 2012 Jun;18(6):799-806. doi: 10.1177/1352458511428081. Epub 2011 Nov 14.

PMID:
22084489
10.

Trends in the epidemiology of multiple sclerosis in Greater Hobart, Tasmania: 1951 to 2009.

Simpson S Jr, Pittas F, van der Mei I, Blizzard L, Ponsonby AL, Taylor B.

J Neurol Neurosurg Psychiatry. 2011 Feb;82(2):180-7. doi: 10.1136/jnnp.2010.215186. Epub 2010 Nov 20.

PMID:
21097824
11.

Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis.

Simpson S Jr, Taylor B, Blizzard L, Ponsonby AL, Pittas F, Tremlett H, Dwyer T, Gies P, van der Mei I.

Ann Neurol. 2010 Aug;68(2):193-203. doi: 10.1002/ana.22043.

PMID:
20695012
12.

Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis.

Pittas F, Ponsonby AL, van der Mei IA, Taylor BV, Blizzard L, Groom P, Ukoumunne OC, Dwyer T.

J Neurol. 2009 Apr;256(4):577-85. doi: 10.1007/s00415-009-0120-2. Epub 2009 Apr 9.

PMID:
19365595
13.

Monthly ambient sunlight, infections and relapse rates in multiple sclerosis.

Tremlett H, van der Mei IA, Pittas F, Blizzard L, Paley G, Mesaros D, Woodbaker R, Nunez M, Dwyer T, Taylor BV, Ponsonby AL.

Neuroepidemiology. 2008;31(4):271-9. doi: 10.1159/000166602. Epub 2008 Oct 30.

PMID:
18971584
14.

Adherence to the immunomodulatory drugs for multiple sclerosis: contrasting factors affect stopping drug and missing doses.

Tremlett H, Van der Mei I, Pittas F, Blizzard L, Paley G, Dwyer T, Taylor B, Ponsonby AL.

Pharmacoepidemiol Drug Saf. 2008 Jun;17(6):565-76. doi: 10.1002/pds.1593.

PMID:
18395883
15.

The effect of season on cytokine expression in multiple sclerosis and healthy subjects.

Stewart N, Taylor B, Ponsonby AL, Pittas F, van der Mei I, Woods G, Walters H.

J Neuroimmunol. 2007 Aug;188(1-2):181-6. Epub 2007 Jul 12.

PMID:
17628701
16.

The cost of multiple sclerosis in Australia.

Taylor B, McDonald E, Fantino B, Sedal L, MacDonnell R, Pittas F, Groom T, Beresniak A.

J Clin Neurosci. 2007 Jun;14(6):532-9. Erratum in: J Clin Neurosci. 2008 Oct;15(10):1189. Beresniak, Ariel [added].

PMID:
17430777
18.

How large should a skin trephine be for an end stoma?

Nguyen MH, Pittas F.

Aust N Z J Surg. 1999 Sep;69(9):675-6.

PMID:
10515344

Supplemental Content

Loading ...
Support Center